Literature DB >> 29128289

Predictors of the response of HbA1c and body weight after SGLT2 inhibition.

T Abe1, Y Matsubayashi1, A Yoshida2, H Suganami3, T Nojima4, T Osawa1, M Ishizawa1, M Yamamoto1, K Fujihara1, S Tanaka5, K Kaku6, H Sone7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29128289     DOI： 10.1016/j.diabet.2017.10.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  3 in total

Review 1.  The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.

Authors:  Merlin C Thomas; David Z I Cherney
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

2.  A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor.

Authors:  You Cheol Hwang; Jae Hyeon Kim; Byung Wan Lee; Woo Je Lee
Journal:  Diabetes Metab J       Date:  2019-06-14       Impact factor: 5.376

3.  A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study.

Authors:  Masaru Kitazawa; Takashi Katagiri; Hiromi Suzuki; Satoshi Matsunaga; Mayuko H Yamada; Tomoo Ikarashi; Masahiko Yamamoto; Kazuo Furukawa; Midori Iwanaga; Mariko Hatta; Kazuya Fujihara; Takaho Yamada; Shiro Tanaka; Hirohito Sone
Journal:  Diabetes Obes Metab       Date:  2021-01-08       Impact factor: 6.577
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.